Clinical Trials Directory

Trials / Sponsors / MerLion Pharmaceuticals GmbH

MerLion Pharmaceuticals GmbH

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedFinafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis
Urinary Tract Infections, Acute Pyelonephritis
Phase 22012-12-01
CompletedPharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin
Safety and Tolerability
Phase 12012-01-01
CompletedSafety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects
Healthy
Phase 12010-09-01
CompletedEffect of Age and Gender on the PK and Tolerability of Finafloxacin
Pharmacokinetic and Tolerability of Finafloxacin
Phase 12010-02-01
CompletedFinafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lowe
Urinary Tract Infections
Phase 22008-10-01
CompletedEfficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients
Gram-Negative Bacterial Infections, Helicobacter Infections, Dyspepsia
Phase 22008-09-01
CompletedFirst Time in Man Study of Finafloxacin Hydrochloride
Helicobacter Infections, Urinary Tract Infection
Phase 12007-08-01
TerminatedFirst Time in Man Trial for Friulimicin B
Community Acquired Pneumonia, Staphylococcal Skin Infections
Phase 12007-06-01